PREMATURE LUTEINIZATION IN ASSISTED REPRODUCTIVE TECHNOLOGY PROTOCOLS USING GONADOTROPIN-RELEASING HORMONE ANALOGUES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The literature review discusses the contribution of the phenomenon of premature luteinization (PL) to the effectiveness of in vitro fertilization protocols using gonadotropin-releasing hormone analogues: the specific features of used terminology, the mechanism for development of PL, its influence on the values of folliculogenesis, oogenesis, embryogenesis, and endometrial receptivity, as well as measures for its prevention.

Full Text

Restricted Access

About the authors

E. V MITYURINA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: mity-elena@yandex.ru

S. G PERMINOVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: perisvet@list.ru

E. R DURINYAN

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: evelina_durinyan@mail.ru

References

  1. Abraham G.E., Chakmakjian Z.H. Serum steroid levels during the menstrual cycle in a bilaterally adrenalectomized woman. J. Clin. Endocrinol. Metab. 1973; 37(4): 581-7.
  2. Kyrou D., Al-Azemi M., Papanikolaou E.G., Donoso P., Tziomalos K., Devroey P., Fatemi H.M. The relationship between premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinantFSH stimulated cycles. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012;162(2): 165-8.
  3. Andersen A.N., Devroey P., Arce J.C.; MERIT Group. Clinical outcome following stimulation with highly purifiedhMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum. Reprod. 2006; 21: 3217-27.
  4. Barash A., Shoham Z., Lunenfeld B., Segal I., Insler V., Borenstein R. Can premature luteinization in superovulation protocols be prevented by aspiration of an ill-timed leading follicle? Fertil. Steril. 1990; 53(5): 865-9.
  5. Bosch E., Labarta E., Crespo C., Simon C., Remohi J., Jenkins J., Pellicer A. Circulation progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum. Reprod. 2010; 25(8): 2092-100.
  6. Bosch E., Valencia I., Escudero E., Crespo J., Simon C., Remohi' J., Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil. Steril. 2003; 80(6): 1444-9.
  7. Bourgain C., Devroey P. The endometrium in stimulated cycles for IVF. Hum. Reprod. Update. 2003; 9(6): 515-22.
  8. Copperman A.B., Horowitz G.M., Kaplan P., Scott R.T., Navot D., Hofmann G.E. Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil. Steril. 1995; 63(6): 1267-71.
  9. De Ziegler D., Bijaoui G., Chapron C. Pre-hCG elevation of plasma progesterone: good, bad or otherwise. Hum. Reprod. Update. 2008; 14(4): 393.
  10. Elnashar A.M. Progesterone rise on day of HCG administration (premature luteinization) in IVF: an overdue update. J. Assist. Reprod. Genet. 2010; 27(4): 149-55.
  11. Escudero E.L., Boerrigter P.J., Bennink H.J., Epifanio R., Horcajadas J.A., Olivennes F. et al. Mifepristone is an effective oral alternative for the prevention of premature luteinization hormone surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. J. Clin. Endocrinol. Metab. 2005; 90(4): 2081-8.
  12. Fatemi H.M., Doody K., Witjes H. et al. A high ovarian response does not compromise the chance of pregnancy. In: Abstracts of the 27th Annual Meeting of the Europian Society of Human Reproduction and Embryology. Stockholm, Sweden, 3-6 July 2011. Stockholm; 2011: 510; Hum. Reprod. 2011; 2 (Suppl. 1).
  13. Filicori M., Cognigni G.E., Gamberini E., Parmegiani L., Troilo E., Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil. Steril. 2005; 84(2): 394-401.
  14. Fleming R. Progesterone elevation on the day of hCG: methodological issue. Hum. Reprod. - 2008; 14: 391-3.
  15. Fleming R., Jenkins J. The source and implication ofprogesterone rise during the follicular phase of assisted reproduction cycles. Reprod. Biomed. Online. 2010; 21(4): 446-9.
  16. Harada T., Katagiri C., Takao N., Toda T., Mio Y., Terakawa N. Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentration improves embryo quality in cycles with subtle P rise. Fertil. Steril. 1996; 65(3): 594-7.
  17. Hofmann G.E., Bentzien F., Bergh P.A., Garrisi G.J., Williams M.C., Guzman I., Navot D. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo qulity. Fertil. Steril. 1993; 60(4): 675-9.
  18. Huang C.C., Lien Y.R., Chen H.F, Chen M.J., Shieh C.J., Yao Y.L. et al. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles. Hum. Reprod. 2012; 27(7): 2036-45.
  19. Judd S., Terry A., Petrucco M., White G. The source of pulsatile secretion of progesterone during the human follicular phase. J. Clin. Endocrinol. Metab. 1992; 74(2): 299-305.
  20. Kilicedag E.B., Haydardedeoglu B., Cok T., Hacivelioglu S.O., Bagis T. Premature progesterone elevation impairs implantation and birth rates in GnRH-agonist IVF/ICSI cycles. Arch. Gynecol. Obstet. 2010; 281(4): 747-52.
  21. Kyrou D., Kolibianakis E.M., Fatemi H.M., Camus M., Tournaye H., Tarlatzis B.C., Devroey P. High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection. Fertil. Steril. 2011; 96(4): 884-8.
  22. Labarta E., Martinez-Conejero J.A., Alama P., Horcajadas J.A., Pellicer A., Simon C., Bosch E. Endometrial receptivity is affected in woman with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum. Reprod. 2011; 26(7): 1813-25.
  23. Lainas T., Zorzovilis J., Petsas G., Stavropoulou G., Cazlaris H., Daskalaki V. et al. In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist in associated with increased pregnancy rates in IVF. Hum. Reprod. 2005; 20(9): 2426-33.
  24. Li R., Qiao J., Wang L., Li L., Zhen X., Liu P., Zheng X. MicroRNA and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod. Biol. Endocrinol. 2011; 9: 29.
  25. Melo M.A., Meseguer M., Garrido N., Bosch E., Pellicer A., Remohi' J. The significance of premature luteinization in an oocyte-donation programme. Hum. Reprod. 2006; 21(6): 1503-7.
  26. Moon Y.S., Tsang B.K., Simpson C., Armstrong D.T. 17 beta-Estradiol biosynthesis in cultured granulosa and thecal cells of human ovarian follicles: stimulation by follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 1978; 47(2): 263-7.
  27. Polotsky A.J., Daif J.L., Jindal S., Lieman H.J., Santoro N., Pal L. Serum progesterone on the day of human chorionic gonadotropin administration predicts clinical pregnancy of sibling frozen embryos. Fertil. Steril. 2009; 92(6): 1880-5.
  28. Schoolcraft W., Sinton E., Schlenker T., Huynh D., Hamilton F., Meldrum D.R. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil. Steril. 1991; 55(3): 563-6.
  29. Silverberg K.M., Burns W.N., Olive D.L., Riehl R.M., Schenken R.S. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J. Clin. Endocrinol. Metab. 1991; 73(4): 797-803.
  30. Shapiro B.S., Daneshmand S.T., Garner F.C., Aguirre M., Hudson C., Thomas S. Embryo cryopreservation rescues cycles with premature luteinization. Fertil. Steril. 2010; 93(2): 636
  31. Strott C.A., Yoshimi T., Ross G.T., Lipsett M.B. Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of HCG. J. Clin. Endocrinol. Metab. 1969; 29(9): 1157-67.
  32. Van Vaerenbergh I., Fatemi H.M., Blockeel C., Van Lommel L., In’t Veld P., Schuit F. et al. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod. Biomed. Online. 2011; 22(3): 26371.
  33. Venetis C.A., Kolibianakis E.M., Papanikolaou E., Bontis J., Devroey P., Tarlatzis B.C. Is progesterone elevation on the day of human chorionic gonadotropin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum. Reprod. Update. 2007; 13(4): 343-55.
  34. Younis J.S., Matilsky M., Radin O., Ben-Ami M. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin releasing hormone agonist. Fertil. Steril. 2001; 76(2): 294-9.
  35. Younis J. S. «Premature luteinization» in the era of GnRH analogue protocols: time to reconsider. J. Assist. Reprod. Genet. 2011; 28(8): 689-92.
  36. Yovel I., Yaron Y., Amit A., Peyser M.R., David M.P., Kogosowski A., Lessing J.B. High progesterone levels adversely affrect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil. Steril. 1995; 64(1): 128-31.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies